Why Perrigo (PRGO) Stock Is Rising Today

NEW YORK (TheStreet) -- Perrigo (PRGO) shares are up 6% to $147.57 on Thursday after beating analysts fourth quarter sales and earnings estimates.

The global healthcare supplier reported an 18% rise in fourth quarter sales to $1.14 billion, ahead of analysts expectations of $1.09 billion.

Profits were up 58% to $1.74 cents, 19 cents better than analysts' guidance.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

TheStreet Ratings team rates PERRIGO CO PLC as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:

"We rate PERRIGO CO PLC (PRGO) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, expanding profit margins, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income."

Highlights from the analysis by TheStreet Ratings Team goes as follows:

PRGO Chart PRGO data by YCharts

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.

If you liked this article you might like

McDonald's Takes Bite Out of Dow, but Nasdaq and S&P 500 at Records

Perrigo Stock Jumps as Starboard's Smith Says Generic Drugs a Strong Business

Valeant CEO Confident Divestitures Can Successfully Pare Debt, Skeptics Remain

These Stocks Have Changed Direction

Stocks Tank as Trump, North Korea Exchange Barbs